Last10K.com

Ac Immune Sa (ACIU) SEC Filing 6-K Foreign Issuer Report for the period ending Friday, June 25, 2021

Ac Immune Sa

HISTORY TOOLS
CIK: 1651625 Ticker: ACIU

View differences made from one to another to evaluate Ac Immune Sa's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Ac Immune Sa.

Continue

Assess how Ac Immune Sa's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Ac Immune Sa's Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Material Contracts, Statements, Certifications & more

Ac Immune Sa provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Additional Exhibits
Exhibit 99.2: Additional Exhibits
Exhibit 99.3: Additional Exhibits
Ticker: ACIU
CIK: 1651625
Form Type: 6-K Foreign Issuer Report
Accession Number: 0000950103-21-009379
Submitted to the SEC: Fri Jun 25 2021 4:31:17 PM EST
Accepted by the SEC: Fri Jun 25 2021
Period: Friday, June 25, 2021
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/aciu/0000950103-21-009379.htm